In the US, Telavancin (telavancin systemic) is a member of the drug class glycopeptide antibiotics and is used to treat Skin and Structure Infection.
US matches:
- Telavancin
- Telavancin Intravenous
- Telavancin Hydrochloride
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
J01XA03
CAS registry number (Chemical Abstracts Service)
0372151-71-8
Chemical Formula
C80-H106-Cl2-N11-O27-P
Molecular Weight
1755
Therapeutic Category
Antibacterial
Chemical Names
N3''-[2-(Decylamino)ethyl)-29-[[(phosphonomethyl)amino]methyl]vancomycin
(3S,6R,7R,22R,23S,26S,36R,38aR)-3-(2-amino-2-oxoethyl)-10,19-dichloro-44-[(3-{[2-(decanylamino)ethyl]amino}-2,3,6-trideoxy-3-C-ethyl-α-L-lyxo-hexopyranosyl-(1->2)-beta-D-glucopyranosyl)oxy]-7,22,28,30,32-pentahydroxy-6-[(2R)-4-methyl-2-(methylamino)pentaa (WHO)
Foreign Names
- Telavancinum (Latin)
- Telavancin (German)
- Télavancine (French)
- Telavancina (Spanish)
Generic Names
- Telavancin Hydrochloride (OS: USAN)
- Td-6424 (IS)
Brand Names
- Vibativ
Astellas, United States; Theravance, United States
International Drug Name Search
Glossary
IS | Inofficial Synonym |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
WHO | World Health Organization |
Click for further information on drug naming conventions and
International Nonproprietary Names.